Alexandria, VA (March 1, 2023) The National Home Infusion Association (NHIA) is proud to announce its 2023-2024 Board of Directors. Beginning this term, the association expanded to 15 the number of board seats on its governing body to provide a broader diversification of infusion provider organizations. Board members serve 3-year terms as representatives for their NHIA member organization. Companies joining the NHIA Board of Directors are:
The remaining members of the Board include:
Chair
John Rademacher, MBA
CEO, Option Care Health
Vice Chair
Gregory LoPresti
CEO, Upstate HomeCare
Second Vice Chair
Dee Grein, MBA
President & GM, OptumRx
Treasurer
Richard Iriye, BSPharm
President, Amerita, Inc.
At-Large
Eric Ho, PharmD
Sr VP, Pharmacy Services, Paragon Healthcare
Past Chair
Tim Affeldt, PharmD
Vice President of Specialty/Infusion Operations,
Fairview Pharmacy Services
Andy Copeland
CEO, ARJ Infusion
Rowena Birnel, BSPharm
CEO, Infusion Solutions Inc.
Noah Franz, PharmD, MHA
Director of Pharmacy,
Froedtert Health Pharmacy Solutions
Kathleen Patrick
President, Chartwell Pennsylvania, LP
Todd Pledger, PharmD
Director of Operations & Pharmacy Services,
Harbin Clinic, LLC
The 2023-2024 Board of Directors will be installed after the NHIA Annual Conference held in Washington, D.C. March 25-29.
#####
NHIA is a trade association that represents companies that provide medically necessary infusion therapies to patients in alternate sites, as well as companies that manufacture and supply infusion and specialty pharmacy products. The association’s mission is to provide advocacy, education, and resources to the home and alternate site infusion community so the patients they serve can lead healthy, independent lives. For more information, visit www.nhia.org.
Last week concluded the 2024 National Home Infusion Association Annual Conference (NHIA 2024), which brings together more than 1,600 home and alternate site infusion professionals for four days of networking, education, and exhibits.
The National Home Infusion Association has announced the finalists for its 2024 Exhibitor Innovation Award. The award recognizes groundbreaking products or services that advance the home and alternate site infusion industry.
CMS released its annual monitoring report[link] on the Medicare Part B Home Infusion Therapy (HIT) Services benefit showing that both provider participation and beneficiary utilization have declined over the past year.
